킴스온라인

주요메뉴 바로가기
본문 바로가기
하단메뉴 바로가기

최근 해외학술대회의 주요 발표내용을 제공합니다.

컨퍼런스 커버리지

Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting

27 January - 1 February, United States

Antenatal corticosteroid reduces neonatal morbidities in late preterm twins

2025-02-28

Antenatal corticosteroid betamethasone administration significantly reduces the risk of neonatal respiratory morbidity in women with twin pregnancies at risk of late preterm delivery, according to the ACTWIN* trial presented at SMFM 2025.
APOSTEL 8: Tocolytic benefit for threatened preterm birth called into question

2025-02-28

In the management of threatened preterm birth between 30 and 34 weeks of gestation, atosiban falls short of improving neonatal outcomes when compared with placebo, according to the results of the APOSTEL 8 trial.
Aspirin for preeclampsia prophylaxis: Does dose matter?

2025-02-28

Doubling up on the daily aspirin dose of 81 mg appears to yield no significant protective effect against the incidence of preeclampsia in high-risk pregnancies, suggests findings from the ASAPP* study presented at SMFM 2025.
Breastfeeding protects women against postpartum CVD

2025-02-28

Women who breastfeed, especially those with prior gestational diabetes mellitus (GDM), appear to have greater protection against long-term atherosclerotic cardiovascular disease (ASCVD), suggest the results of a study presented at SMFM 2025.
Postpartum diuretics use eases persistent hypertension

2025-02-28

The postpartum use of diuretics can reduce persistent hypertension in women with hypertensive disorders of pregnancy (HDP), according to the results of a systematic review and meta-analysis presented at SMFM 2025.
Severe maternal morbidity up by fourfold in presence of CRC

2025-02-28

Pregnant women with colorectal cancer (CRC) face a considerably increased likelihood of severe maternal morbidity, including disseminated intravascular coagulation, acute respiratory distress syndrome, and hysterectomy, among others, according to a study.
Single-dose IV iron may be effective first-line treatment for maternal IDA

2025-02-28

Administration of single-dose intravenous (IV) iron during the early second trimester of pregnancy reduced the incidence of low birth weight (LBW) infants and achieved nonanaemic status (NAS) at delivery, according to a study presented at SMFM 2025.
Studies support nifedipine for postpartum hypertension management

2025-02-28

Data presented at SMFM 2025 favour nifedipine over labetalol for the management of hypertension in the postpartum period.

1

최근 본 콘텐츠

최근 본 콘텐츠가 없습니다

TOP

주식회사 킴스

주식회사 킴스 | 광고/제휴문의 | 이용약관 | 개인정보처리방침 | 법적 책임의 한계 | 서비스 전체보기

서울특별시 강남구 테헤란로 8길 33 청원빌딩 1층 (주)킴스
개인정보관리책임자 : 최동섭 사업자등록번호 : 214-81-75415 통신판매업신고 : 강남-5166호 대표이사 : 마사키 타카하타
고객센터 : 1544-2930 (10:00~17:00, 주말/공휴일 제외) 팩스 : 02-3019-9380 e-mail : webmaster@kims.co.kr

Copyright © 1987-2025 KIMS Co., Ltd All Rights Reserved

KIMS 페이스북

KIMS 유튜브